000 | 01983 a2200565 4500 | ||
---|---|---|---|
005 | 20250517093317.0 | ||
264 | 0 | _c20170817 | |
008 | 201708s 0 0 eng d | ||
022 | _a1872-8421 | ||
024 | 7 |
_a10.1016/j.jneuroim.2016.03.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCatanzaro, G | |
245 | 0 | 0 |
_aEpigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis. _h[electronic resource] |
260 |
_bJournal of neuroimmunology _c05 2016 |
||
300 |
_a32-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a5-Methylcytosine _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aArachidonate 5-Lipoxygenase _xmetabolism |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCytokines _xgenetics |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopamine and cAMP-Regulated Phosphoprotein 32 _xmetabolism |
650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _ximmunology |
650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMyelin-Oligodendrocyte Glycoprotein _ximmunology |
650 | 0 | 4 |
_aNeurons _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type I _xmetabolism |
650 | 0 | 4 |
_aPeptide Fragments _ximmunology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aras Proteins _xgenetics |
700 | 1 | _aPucci, M | |
700 | 1 | _aViscomi, M T | |
700 | 1 | _aLanuti, M | |
700 | 1 | _aFeole, M | |
700 | 1 | _aAngeletti, S | |
700 | 1 | _aGrasselli, G | |
700 | 1 | _aMandolesi, G | |
700 | 1 | _aBari, M | |
700 | 1 | _aCentonze, D | |
700 | 1 | _aD'Addario, C | |
700 | 1 | _aMaccarrone, M | |
773 | 0 |
_tJournal of neuroimmunology _gvol. 294 _gp. 32-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jneuroim.2016.03.009 _zAvailable from publisher's website |
999 |
_c25980920 _d25980920 |